Pulmonary

Apr 2, 2002

Simplified Practical Chart of Pulmonary
Vascular Segmental Anatomy.

Cote rendition of a practical pulmonary segmental chart to be used for the interpretation of V/Q lung scans.

[Table of Content]

A Rk Nx1 Fop15 Je H Jffj8rq D13

TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies

April 22, 2026

Ionetix raises $30M to scale radioisotope production

April 21, 2026

Molecular Imaging News Platform: trends, insights, professional views.

Molecular Imaging News Platform: trends, insights, professional views.

April 14, 2026

Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.

Shine receives $263M conditional loan for Mo-99 isotope facility

April 9, 2026

TAG1, NRG Pallas to advance Pb-212 supply for cancer therapies

By AuntMinnie.com staff writers

TAG1 and NRG Pallas aim to develop access to lead-212 (Pb-212) for cancer drug development across Europe.

April 22, 2026

A Rk Nx1 Fop15 Je H Jffj8rq D13

Ionetix raises $30M to scale radioisotope production

By AuntMinnie.com staff writers

The funding will support scaling up of radioisotope production as well as R&D efforts in nuclear energy, materials testing, and related areas.

April 21, 2026

Telix doses first patient in glioblastoma trial

By AuntMinnie.com staff writers

The patient was dosed at Austin Health in Melbourne, Australia.

April 15, 2026

Shine receives $263M conditional loan for Mo-99 isotope facility

By AuntMinnie.com staff writers

Shine has received a conditional loan from the U.S. DOE to complete the Chrysalis medical isotope production facility for Mo-99.

April 9, 2026

Chrysalis, Shine’s large-scale irradiation facility, will complement the existing supply chain with the goal of ensuring a sustainable and reliable source of isotopes, including Mo-99.

First patients treated in RYZ401 radiopharmaceutical trial

By AuntMinnie.com staff writers

RYZ401 is an investigational actinium-225 (AC-225)-based radiopharmaceutical targeting somatostatin receptors in neuroendocrine tumors.

April 8, 2026

Consortium launches 5-year plan to improve theranostics outcomes

The project aims to pave the way for personalized radiopharmaceutical therapy.

April 6, 2026

SpectronRx raises $85M to expand radiopharmaceutical production

By AuntMinnie.com staff writers

The funding will support infrastructure investment at the company's Grissom Aeroplex campus in Indiana.

April 2, 2026

Cardinal Health expands Ac-225 production

By AuntMinnie.com staff writers

Since launching routine Ac-225 production at scale in late 2024, the company said it has quadrupled its weekly output.

April 1, 2026

Radiopharmaceutical Therapy Tracker

With so many targeted diagnostic and therapeutic radiopharmaceuticals in development for cancer care, AuntMinnie's new pipeline update tool can help keep track.

March 30, 2026

Varian nets FDA clearance for TrueBeam in osteoarthritis treatment

By AuntMinnie.com staff writers

Varian has received U.S. FDA clearance for the use of low-dose radiation therapy with its Varian TrueBeam radiotherapy systems.

March 19, 2026

TrueBeam radiotherapy system

TerraPower Isotopes to build Ac-225 facility in Philadelphia

By AuntMinnie.com staff writers

The new site will increase the company's actinium-225 (Ac-225) production capacity 20-fold.

March 18, 2026

JAMA study shows wide global variation in cardiac imaging radiation dose

By Kate Madden Yee

"Radiation doses varied significantly between imaging tests and among patients receiving the same tests," researchers reported.

February 25, 2026

Radiation Symbols Adobe Mia

Page 1 of 441